LQ-23

N/A

Report date: 2024/04/12 15:31:51
NME

Base Information

Drug NameLQ-23
Drug Alias NameLQ23LQ-23
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDual specificity protein kinase CLK2 inhibitors
TargetsDual specificity protein kinase CLK2
Therapy Area/IndicationsOsteoarthritis, Knee
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesChina Pharmaceutical University
China Registration ClassN/A

Develop Information

Active CompaniesChina Pharmaceutical University
Inactive CompaniesN/A
Active IndicationsOsteoarthritis, Knee
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A